Natalizumab-Related Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis: Findings from an Italian Independent Registry

BACKGROUND: The monoclonal antibody natalizumab (NTZ) is a highly effective treatment for patients with multiple sclerosis (MS). However, this drug is associated with increased risk of developing Progressive Multifocal Leukoencephalopathy (PML), an opportunistic infection of central nervous system (...

Descripción completa

Detalles Bibliográficos
Autores principales: Prosperini, Luca, de Rossi, Nicola, Scarpazza, Cristina, Moiola, Lucia, Cosottini, Mirco, Gerevini, Simonetta, Capra, Ruggero
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5172579/
https://www.ncbi.nlm.nih.gov/pubmed/27997580
http://dx.doi.org/10.1371/journal.pone.0168376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5172579/
https://www.ncbi.nlm.nih.gov/pubmed/27997580
http://dx.doi.org/10.1371/journal.pone.0168376

Ejemplares similares